Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 4Unknown 2Terminated 2Withdrawn 1Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 10Lymphoid 2Sarcoma 1Plasma cell 1

Conditions

Lymphoma 2Lymphoma, Large-Cell, Anaplastic 1

Interventions

Cyclophosphamide 139Rituximab 115Etoposide 77Vincristine 75Doxorubicin 62Cytarabine 61Dexamethasone 58Prednisone 55fludarabine 52Methotrexate 46N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 42Lenalidomide 37Gemcitabine 35Radiotherapy 29Melphalan 27pegaspargase 22Prednisolone 22Ifosfamide 22fludarabine phosphate 20Busulfan 20Cisplatin 19Bendamustine Hydrochloride 19Asparaginase 18Peripheral Blood Stem Cell Transplantation 17ibrutinib 16Decitabine 16Carmustine 16Mercaptopurine 15Filgrastim 15Oxaliplatin 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Lomustine × Lymphoid × Clear all
NCT00317408 2015-09-25

Combination Chemotherapy Followed By Stem Cell Transplant in Treating Young Patients With Progressive or Relapsed Anaplastic Large Cell Lymphoma

National Cancer Institute (NCI)

Phase NA Unknown
96 enrolled
Lymphoid

Lymphoma, Lymphoma, Large-Cell, Anaplastic

NCT00989352 2009-10-05

PRIMAIN

University Hospital Freiburg

Phase 2 Unknown
56 enrolled
Lymphoid

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡